Primary intraocular lymphoma (PIOL) is an ocular malignancy that is a subset of primary
central system lymphoma (PCNSL). Approximately one-third of PIOL patients will have …

Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

Background Using an updated dataset with more patients and extended follow-up, we further
established cancer patient characteristics associated with COVID-19 death. Methods Data …

Resisting cell death is one of the six hallmarks of cancer. Autophagy is a highly adaptable
metabolic process that plays an important role in stressful conditions, such as nutrient …

Patients with cancer are considered to be at high-risk for SARS-CoV-2 infection and severe
COVID-19 (Bakouny et al., 2020). Our ‘‘SOAP-02’’(Sars-CoV-2 fOr cAncer Patients) study …

Background: There is insufficient evidence to support clinical decision-making for cancer
patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data …

Bevacizumab is considered an established part of the treatment strategies available for
schwannomas in patients with Neurofibromatosis type 2 (NF2). In the UK, it is available through …

Despite the refinement of modern cataract surgery, postoperative inflammation still
constitutes a substantial amount of visual morbidity worldwide. A surrogate for intraocular …

Purpose To compare [ 18 F]-fluorodeoxyglucose (FDG) and [ 18 F]-sodium fluoride (NaF)
positron emission tomography/computed tomography (PET/CT) with whole-body magnetic …

Background In the phase III OlympiAD trial, olaparib significantly increased progression-free
survival (PFS) compared with chemotherapy of physician's choice in patients with germline …